Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-020787
Filing Date
2021-02-11
Accepted
2021-02-11 17:03:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm216286d1_424b5.htm 424B5 411619
2 GRAPHIC tm216286d1_424b5img001.jpg GRAPHIC 10223
3 GRAPHIC tm216286d1_424b5img002.jpg GRAPHIC 11396
  Complete submission text file 0001104659-21-020787.txt   442935
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230604 | Film No.: 21620690
SIC: 2836 Biological Products, (No Diagnostic Substances)